Literature DB >> 21120445

Novel dominant-negative mutant of GATA3 in HDR syndrome.

Masaaki Ohta1, Minenori Eguchi-Ishimae, Mayumi Ohshima, Hidehiko Iwabuki, Koji Takemoto, Kikuko Murao, Toshiyuki Chisaka, Eiichi Yamamoto, Takashi Higaki, Keiichi Isoyama, Mariko Eguchi, Eiichi Ishii.   

Abstract

HDR syndrome is an autosomal dominant disorder characterized by hypoparathyroidism, sensorineural deafness, and renal anomaly caused by mutation of the GATA3 gene located at chromosome 10p15. We report the case of a neonate with HDR syndrome and a novel GATA3 mutation. We performed genetic and functional analysis of GATA3 in this patient and identified a novel heterozygous 1516G> C missense mutation in exon 5, resulting in a cysteine-to-serine substitution at codon 321 (Cys321Ser). Mutated and wild-type GATA3 proteins were expressed at a similar level in vitro, indicating that the mutated GATA3 protein was stable. Luciferase assay revealed that the Cys321Ser-mutated GATA3 lacked transactivation activity due to loss of DNA-binding activity as confirmed by gel shift assay. Moreover, mutated GATA3 exerted a dominant-negative effect over the transactivation activity of wild-type GATA3. These findings indicate that not only haploinsufficiency of GATA3 but also the dominant-negative effect of Cys321Ser-mutated GATA3 might have been responsible for the HDR syndrome phenotype of our patient.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21120445     DOI: 10.1007/s00109-010-0702-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  32 in total

1.  GATA3 abnormalities and the phenotypic spectrum of HDR syndrome.

Authors:  K Muroya; T Hasegawa; Y Ito; T Nagai; H Isotani; Y Iwata; K Yamamoto; S Fujimoto; S Seishu; Y Fukushima; Y Hasegawa; T Ogata
Journal:  J Med Genet       Date:  2001-06       Impact factor: 6.318

2.  A novel heterozygous deletion frameshift mutation of GATA3 in a Japanese kindred with the hypoparathyroidism, deafness and renal dysplasia syndrome.

Authors:  H Kobayashi; M Kasahara; M Hino; H Yoshimura; S Takahara; K Ikeda; C Son; T Iwakura; A Yoshimoto; T Ishihara; Y Ogawa
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

Review 3.  HDR syndrome (hypoparathyroidism, sensorineural deafness, renal dysplasia) associated with del(10)(p13).

Authors:  T Hasegawa; Y Hasegawa; T Aso; S Koto; T Nagai; Y Tsuchiya; K C Kim; H Ohashi; K Wakui; Y Fukushima
Journal:  Am J Med Genet       Date:  1997-12-31

4.  GATA3 haploinsufficiency causes a rapid deterioration of distortion product otoacoustic emissions (DPOAEs) in mice.

Authors:  M A J van Looij; H van der Burg; R S van der Giessen; M M de Ruiter; J van der Wees; J H van Doorninck; C I De Zeeuw; G A van Zanten
Journal:  Neurobiol Dis       Date:  2005-07-01       Impact factor: 5.996

5.  Identification of three novel mutations in the GATA3 gene responsible for familial hypoparathyroidism and deafness in the Chinese population.

Authors:  Wei-Yih Chiu; Huan-Wen Chen; Hwei-Wen Chao; Lee-Tzong Yann; Keh-Sung Tsai
Journal:  J Clin Endocrinol Metab       Date:  2006-08-15       Impact factor: 5.958

6.  FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation.

Authors:  A P Tsang; J E Visvader; C A Turner; Y Fujiwara; C Yu; M J Weiss; M Crossley; S H Orkin
Journal:  Cell       Date:  1997-07-11       Impact factor: 41.582

7.  Hearing loss following Gata3 haploinsufficiency is caused by cochlear disorder.

Authors:  Jacqueline van der Wees; Marjolein A J van Looij; M Martijn de Ruiter; Helineth Elias; Hans van der Burg; Su-San Liem; Dorota Kurek; J Doug Engel; Alar Karis; Bert G A van Zanten; Chris I de Zeeuw; Frank G Grosveld; J Hikke van Doorninck
Journal:  Neurobiol Dis       Date:  2004-06       Impact factor: 5.996

8.  Case of hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome associated with nephrocalcinosis and distal renal tubular acidosis.

Authors:  Yuji Kato; Naoki Wada; Atsushi Numata; Hidehiro Kakizaki
Journal:  Int J Urol       Date:  2007-05       Impact factor: 3.369

9.  A missense GATA3 mutation, Thr272Ile, causes the hypoparathyroidism, deafness, and renal dysplasia syndrome.

Authors:  Katherine U Gaynor; Irina V Grigorieva; M Andrew Nesbit; Treena Cranston; Thushari Gomes; Ludwig Gortner; Rajesh V Thakker
Journal:  J Clin Endocrinol Metab       Date:  2009-09-01       Impact factor: 5.958

10.  Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.

Authors:  M Andrew Nesbit; Michael R Bowl; Brian Harding; Asif Ali; Alejandro Ayala; Carol Crowe; Angus Dobbie; Geeta Hampson; Ian Holdaway; Michael A Levine; Robert McWilliams; Susan Rigden; Julian Sampson; Andrew J Williams; Rajesh V Thakker
Journal:  J Biol Chem       Date:  2004-02-24       Impact factor: 5.157

View more
  5 in total

1.  Renal phenotypic variability in HDR syndrome: glomerular nephropathy as a novel finding.

Authors:  Alexis Chenouard; Bertrand Isidor; Emma Allain-Launay; Anne Moreau; Marc Le Bideau; Gwenaelle Roussey
Journal:  Eur J Pediatr       Date:  2012-10-05       Impact factor: 3.183

2.  Auditory and vestibular phenotypes associated with GATA3 mutation.

Authors:  Wade Wei-De Chien; Jennifer W Leiding; Amy P Hsu; Christopher Zalewski; Kelly King; Steven M Holland; Carmen Brewer
Journal:  Otol Neurotol       Date:  2014-04       Impact factor: 2.311

3.  Juvenile idiopathic arthritis associated with a mutation in GATA3.

Authors:  Anna E Patrick; Wei Wang; Elly Brokamp; Thomas Brent Graham; Thomas M Aune; Jessica B Duis
Journal:  Arthritis Res Ther       Date:  2019-06-25       Impact factor: 5.156

4.  Transactivation of human osteoprotegerin promoter by GATA-3.

Authors:  Shyan-Yuan Kao; Konstantina M Stankovic
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

5.  A Novel De Novo GATA Binding Protein 3 Mutation in a Turkish Boy with Hypoparathyroidism, Deafness, and Renal Dysplasia Syndrome.

Authors:  Gül Yeşiltepe Mutlu; Heves Kırmızıbekmez; Akie Nakamura; Maki Fukami; Şükrü Hatun
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.